Cargando…
hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen
Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) offer a novel in vitro platform for pre-clinical cardiotoxicity and pro-arrhythmia screening of drugs in development. To date hiPSC-CMs used for cardiotoxicity testing display an immature, fetal-like cardiomyocyte structural and...
Autores principales: | da Rocha, André Monteiro, Campbell, Katherine, Mironov, Sergey, Jiang, Jiang, Mundada, Lakshmi, Guerrero-Serna, Guadalupe, Jalife, José, Herron, Todd J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653750/ https://www.ncbi.nlm.nih.gov/pubmed/29061979 http://dx.doi.org/10.1038/s41598-017-13590-y |
Ejemplares similares
-
Human perinatal stem cell derived extracellular matrix enables rapid maturation of hiPSC-CM structural and functional phenotypes
por: Block, Travis, et al.
Publicado: (2020) -
High-throughput longitudinal electrophysiology screening of mature chamber-specific hiPSC-CMs using optical mapping
por: Allan, Andrew, et al.
Publicado: (2023) -
The three-dimensionality of the hiPSC-CM spheroid contributes to the variability of the field potential
por: Hwang, Minki, et al.
Publicado: (2023) -
Engineering hiPSC-CM and hiPSC-EC laden 3D nanofibrous splenic hydrogel for improving cardiac function through revascularization and remuscularization in infarcted heart
por: Guan, Ge, et al.
Publicado: (2021) -
An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes
por: McKeithan, Wesley L., et al.
Publicado: (2017)